“The proposed registration requirements for telemedicine-based prescribing and dispensing create a new business activity within DEA’s overarching registration framework, distinguishing it from ...
The Drug Enforcement Administration ("DEA") announced three new regulations related to the prescription of controlled substances resulting from ...
The U.S. Drug Enforcement Administration (DEA) recently announced new rules that will impact telemedicine practices, especially concerning ...
Healthcare executives are calling on the Trump Administration to nullify a DEA proposal to create a special registration for ...
The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth ...
Scammers are targeting health care professionals in Connecticut, in some cases stealing hundreds of thousands of dollars. The ...
On Wednesday, the DEA released a proposed rule that would set up a special registration process for remote prescribing of Schedule II-V controlled substances such as Xanax, Vicodin and Adderall.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback